Diseases

New AI tool revolutionises multiple sclerosis treatment monitoring

Researchers at University College London (UCL) have developed an innovative artificial intelligence (AI) tool called MindGlide, designed to transform the way multiple sclerosis (MS) treatments are assessed.

Survey finds 30% of people with PCOS rely on online forums for information

There is little mainstream awareness of the condition that impacts one in ten women - currently, 30% of people with Polycystic ovary syndrome (PCOS) rely on online forums for information.

HealthTracker™ for patients, clinician & researchers

Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.

Biosimilars: Improve access to treatment & reduce cost

Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.

Curative approach to severe autoimmune diseases

Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.

A simple prescription for healing chronic disease

Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.

From insulin to immunotherapy: A century of discovery

Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.

Plague: The first pandemic disease

Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.

COVID-19 and diabetes telehealth

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.

Supporting adolescent girls from refugee backgrounds

Chief Talent & Global Strategy Officer Dr Dianne Morrison-Beedy highlights the major issue of how adolescent girls from refugee backgrounds have been forgotten in evidence-based sexual risk reduction interventions.

The role of the mind in dis-ease

We hear from emotional trauma expert and renowned healer, Antonia Harman about the role of the mind in dis-ease.

Heart failure drug may treat COVID-19 long-hauler symptom

Researchers have found that an existing heart failure drug can improve the symptoms associated with postural orthostatic tachycardia syndrome.

UK collaboration will revolutionise rare disease treatment

The Medicines Manufacturing Innovation Centre (MMIC) has developed a scalable, sustainable and more cost-effective way to manufacture oligonucleotides and treat rare diseases.

Treating bovine tuberculosis (bTB) with artificial intelligence

Craig Rhodes, EMEA Industry Lead for Artificial Intelligence Healthcare and Life Science at NVIDIA, explores how bovine tuberculosis (bTB) can be monitored and treated more effectively and efficiently using Artificial Intelligence (AI).

Childhood trauma linked to multiple sclerosis development

Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.

Changing mealtimes could prevent type 2 diabetes

In a new study, researchers will examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.

New framework to improve diagnosis and treatment of rare diseases

The new UK Rare Diseases Framework sets out to accelerate diagnosis and improve the treatment of rare diseases.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders